Abivax S.a. Share Price

NASDAQ: ABVX

Small Cap

$83.29

+2.29

(+2.83%)

Live

as on September 18, 2025 at 11:37 pm IST

$₹

Abivax S.a. Stock Performance

as on September 18, 2025 at 11:37 pm IST

Day's Low
Day's High
$80.11
Day's Price Range
$84.4
$83.29
3.82%
Downside
1.33%
Upside
52 Week's Low
52 Week's High
$4.77
52-Week Price Range
$92.91
$83.29
94.27%
Downside
11.55%
Upside

Abivax S.a. share price movements today

Previous Close: $81.00
Open: $80.80
Volume: 670.7K
Day's Low - High: $80.11 - $84.4
52 Week Low - High: $4.77 - $92.91

Abivax S.a. Historical Returns

1 Month Return: + 15.7 %
3 Month Return: + 1238.84 %
1 Year Return: + 612.4 %
3 Year Return: 0 %
5 Year Return: 0 %

Abivax S.a. Stock Fundamentals & Key Indicators

Check Abivax S.a. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.4B

EPS (TTM)

-3.4314

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-185.7M

Revenue (TTM)

6.0M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Abivax S.a. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abivax S.a. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Abivax S.a.	BUY	$6.4B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Abivax S.a. Stock including INR - Dollar returns

The Abivax S.a. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y

Abivax S.a. investment value today

Current value as on today

₹7,37,495

Returns

₹6,37,495

(+637.49%)

Returns from Abivax S.a. Stock

₹6,32,542 (+632.54%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Abivax S.a. Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Abivax S.a.. Average target price of $104.5

Abivax S.a. Share Price Target

Get share price movements and forecasts by analysts on Abivax S.a..

What analysts predicted

20.3%UPSIDE

Target Price

$104.5

Current Price

$83.29

Analyzed by

14 Analysts

Target

$104.50

Abivax S.a. target price $104.5, a slight upside of 20.3% compared to current price of $83.29. According to 14 analysts rating.

Abivax S.a. Stock's Interest Amongst Investors

Search interest for Abivax S.a. Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-58% versus previous 30 day period

Abivax S.a. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Jun 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	2	2	2	-	3	7	-	2
Gross Profit	2	2	2	-	3	7	-	2
Operating Income	-38	-39	-92	-44	-39	-132	-47	-93
EBITDA	-36	-39	-92	-	-39	-131	-	-93
Interest Expense	1	14	5	2	3	-	4	3
Depreciation	-	-	-	0	0	-	0	0
Income Before Tax	-42	-54	-98	-42	-40	-135	-52	-100
Income Tax Expense	-2	-2	-2	-	-	-	-	-
Net Income	-42	-56	-95	-46	-43	-94	-56	-100
Net Profit Margin	-1792.39%	-2311.08%	-4118.10%	0.00%	-1203.04%	-1278.61%	0.00%	-4996.73%

Abivax S.a. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	0	4	5	10
Gross Profit	0	-14	0	0	-31	-41	0	4	4	10
Operating Income	-18	-18	-14	-19	-33	-38	-41	-64	-127	-172
EBITDA	-18	-18	-13	-19	-33	-37	-38	-53	-133	-171
Interest Expense	0	0	0	0	1	2	3	6	13	12
Depreciation	-	-	-	-	0	0	0	0	0	1
Income Before Tax	-18	-17	-14	-19	-34	-40	-42	-74	-152	-176
Income Tax Expense	-2	-3	-2	-3	-4	-2	-4	-4	-4	-
Net Income	-15	-14	-11	-15	-34	-45	-47	-64	-161	-176
Net Profit Margin	-37985.71%	-11266.14%	-112230.00%	-87905.56%	-1531700.00%	-59604.76%	-114735.14%	-1325.33%	-3197.14%	-1633.08%

Abivax S.a. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-40	-25	-51	-95	-42	-40	-94	-52	-100
Operating Cash Flow	-39	-13	-27	-71	-34	-42	-68	-33	-66
Investing Cash Flow	0	0	-1	-8	-	13	1	-	1
Financing Cash Flow	40	58	117	222	21	40	-12	-7	-16
Change in Cash	0	43	87	137	-10	-19	-	-40	60

Abivax S.a. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	-14	-19	-33	-38	-42	-60	-147	-176
Operating Cash Flow	-15	-8	-14	-27	-29	-45	-53	-100	-154
Investing Cash Flow	0	0	0	0	0	-1	-12	-10	15
Financing Cash Flow	0	2	10	24	49	78	32	340	28
Change in Cash	-16	-5	-4	-3	19	31	-33	224	-107

Insights on Abivax S.a.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ABVX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, ABVX stock has moved up by 1238.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 7.39M → 2.01M (in $), with an average decrease of 72.7% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -52.37M → -100.78M (in $), with an average decrease of 92.5% per quarter

About Abivax S.a.

Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

Organisation	Abivax S.a.
Headquarters	7-11 boulevard Haussmann, Paris, France, 75009
CEO	Mr. Marc M. P. de Garidel M.B.A.
E-voting on shares	Click here to vote

Key Management of Abivax S.a.

Name	Title
Chris Rabbat Ph.D.	VP & Global Head of Medical Affairs
Mr. Marc M. P. de Garidel M.B.A.	CEO & Director
Mr. Didier Blondel	EVP, CFO & Board Secretary
Mr. Didier Scherrer Ph.D.	Chief Scientific Officer
Ms. Ida Hatoum	Chief People & Compliance Officer
Hema Keshava	Senior Vice President of Finance
Mr. Patrick Malloy	Senior Vice President of Investor Relations
Mr. Pierre Courteille M.B.A.	Chief Business Officer
Mr. Jerome Denis Ph.D.	Executive Vice President of Process Development & Manufacturing
Kevin Shan Ph.D.	VP & Global Head of Biometrics

FAQs

What is Abivax S.a. share price today?

Abivax S.a. share price today is $83.29 as on September 18, 2025 at 11:37 pm IST. Abivax S.a. share today touched a day high of $84.4 and a low of $80.11.

What is the 52 week high and 52 week low for Abivax S.a. share?

Abivax S.a. share touched a 52 week high of $92.91 on September 5, 2025 and a 52 week low of $4.77 on April 9, 2025. Abivax S.a. stock price today i.e. September 18, 2025 at 11:37 pm IST is trending at $83.29,which is 10.35% down from its 52 week high and 1646.12% up from its 52 week low.

What is Abivax S.a.'s market capitalisation today?

Abivax S.a. market capitalisation is $0.01T as on September 18, 2025 at 11:37 pm IST.

How to invest in Abivax S.a. Stock (ABVX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Abivax S.a. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abivax S.a. Shares that will get you 0.0180 shares as per Abivax S.a. share price of $83.29 per share as on September 18, 2025 at 11:37 pm IST.

What is the minimum amount required to buy Abivax S.a. Stock (ABVX) from India?

Indian investors can start investing in Abivax S.a. (ABVX) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 11:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Abivax S.a. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 11:37 pm IST). Based on Abivax S.a. share’s latest price of $83.29 as on September 18, 2025 at 11:37 pm IST, you will get 0.1201 shares of Abivax S.a.. Learn more about fractional shares .